Market Overview:
The global high potency active pharmaceutical ingredients (HPAPI) market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for HPAPIs for the treatment of various diseases, such as oncology, hormonal disorders, and glaucoma. In addition, the growing focus on R&D activities for the development of novel HPAPIs is also contributing to the growth of this market. Oncology is currently one of the key application areas for HPAPIs and is expected to continue its dominance during the forecast period. This can be attributed to rising incidences of cancer across different geographies and growing awareness about available treatments options among patients and healthcare professionals alike. Hormonal disorders are another major application area for HPAPIs owing to their ability to provide relief from various symptoms associated with these disorders without causing any significant side effects.
 Industry Outlook.svg)
Product Definition:
HPAPI is an important term in the pharmaceutical industry. It refers to drugs that are particularly potent and active. These ingredients are used in medications that require a high level of potency, such as cancer treatments and other life-saving therapies.
Synthetic HPAPIs:
The global synthetic HPAPIs market size was valued at USD 4.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growth can be attributed to factors such as increasing demand for advanced therapeutics, rising prevalence of chronic diseases, and growing geriatric population base across the globe.
Biotech HPAPIs:
The global biotech HPAPIs market size was valued at USD 2.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
Oncology accounted for the largest revenue share in 2016 owing to increasing cancer prevalence and an increase in the number of cancer patients. The hormonal segment is also expected to witness significant growth during the forecast period due to a rise in demand for oral contraceptives, testosterone replacement therapy, and other hormone replacement therapies.
Glaucoma is another major segment that is expected to grow at a lucrative rate over the forecast period owing to an increase in glaucoma surgeries globally as well as locally. Glaucoma drugs are highly effective but they have narrow margins of safety because they can produce very serious side effects such as vision loss if not taken correctly by patients.
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market over the forecast period. The growth of this region can be attributed to increasing R&D activities and rising healthcare spending in emerging economies such as China, India, and South Korea. In addition, factors such as favorable government policies for research grants by various agencies are anticipated to boost demand for pharmaceutical products in this region.
Europe accounted for a major share of revenue generation owing to high demand from end-use industries coupled with stringent regulations on manufacturing practices by regulatory authorities like EMEA and FDA.
Growth Factors:
- Increasing demand for high potency drugs: The global market for HPAPI is expected to grow at a CAGR of 6.5% from 2016 to 2021. This growth can be attributed to the increasing demand for high potency drugs, especially in the developed countries.
- Growing prevalence of cancer and other chronic diseases: The growing prevalence of cancer and other chronic diseases is also contributing to the growth of the HPAPI market. Cancer is one of the leading causes of death worldwide, and this trend is expected to continue in the coming years due to rising population and aging population.
- Technological advancements in HPAPI synthesis: The technological advancements in HPAPI synthesis are helping manufacturers produce these molecules more efficiently and at lower costs. This is resulting in an increase in their adoption by pharmaceutical companies across the globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Research Report
By Type
Synthetic HPAPIs, Biotech HPAPIs
By Application
Oncology, Hormonal, Glaucoma, Others
By Companies
Alkermes, Cambrex, Dishman, Dr. Reddy’S, Lonza, Novasep, Thermo Fisher Scientific, Pfizer, Merck Kgaa, Tapi Teva, Alkermes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report Segments:
The global High Potency Active Pharmaceutical Ingredients (HPAPI) market is segmented on the basis of:
Types
Synthetic HPAPIs, Biotech HPAPIs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Hormonal, Glaucoma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alkermes
- Cambrex
- Dishman
- Dr. Reddy’S
- Lonza
- Novasep
- Thermo Fisher Scientific
- Pfizer
- Merck Kgaa
- Tapi Teva
- Alkermes
 Market Overview.svg)
Highlights of The High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Synthetic HPAPIs
- Biotech HPAPIs
- By Application:
- Oncology
- Hormonal
- Glaucoma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High Potency Active Pharmaceutical Ingredients (HPAPI) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HPAPI is a term used to describe active pharmaceutical ingredients (APIs) that have been specifically designed to be more potent than traditional APIs. HPAPI can be more effective in treating certain medical conditions, and they are often prescribed by doctors as part of treatment plans.
Some of the major players in the high potency active pharmaceutical ingredients (hpapi) market are Alkermes, Cambrex, Dishman, Dr. Reddy’S, Lonza, Novasep, Thermo Fisher Scientific, Pfizer, Merck Kgaa, Tapi Teva, Alkermes.
The high potency active pharmaceutical ingredients (hpapi) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 High Potency Active Pharmaceutical Ingredients (HPAPI) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the High Potency Active Pharmaceutical Ingredients (HPAPI) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size & Forecast, 2020-2028
4.5.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size and Y-o-Y Growth
4.5.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Synthetic HPAPIs
5.2.2 Biotech HPAPIs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Hormonal
6.2.3 Glaucoma
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Synthetic HPAPIs
9.6.2 Biotech HPAPIs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Hormonal
9.10.3 Glaucoma
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Synthetic HPAPIs
10.6.2 Biotech HPAPIs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Hormonal
10.10.3 Glaucoma
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Synthetic HPAPIs
11.6.2 Biotech HPAPIs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Hormonal
11.10.3 Glaucoma
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Synthetic HPAPIs
12.6.2 Biotech HPAPIs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Hormonal
12.10.3 Glaucoma
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Synthetic HPAPIs
13.6.2 Biotech HPAPIs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Hormonal
13.10.3 Glaucoma
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Market: Competitive Dashboard
14.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alkermes
14.3.2 Cambrex
14.3.3 Dishman
14.3.4 Dr. Reddy’S
14.3.5 Lonza
14.3.6 Novasep
14.3.7 Thermo Fisher Scientific
14.3.8 Pfizer
14.3.9 Merck Kgaa
14.3.10 Tapi Teva
14.3.11 Alkermes
